Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
Boeing's troubled capsule won't carry astronauts on next space station flight- Best bar-b-que Style: Which One Is Your Number one?
- Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application
- Three arrested in Paris after attempted bomb attack outside Bank of America
- Historic underwater structure discovered by divers off French coast
- 5 Indoor Plants That Further develop Air Quality
- Let them eat (Taylor Swift) cake: The baker turning A-listers into life-size desserts
- JFK's granddaughter reveals terminal cancer diagnosis, criticizes cousin RFK Jr.
- Wolf Bites Woman in Shocking Attack at Busy Shopping Center
